维普中文期刊产品整合服务
31篇 您的检索式:作者名="Vittinghoff M"
    题名 作者 年代 出处 被引量
1Urine biomarkers neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) have different patterns in heart failure Exacerbation显示文摘Park M Vittinghoff E Liu KD 2013Biomarker insights2013,8,3:1
2Estrogen and progestin,lipoprotein(a),and the risk of recurrent coronary heart disease events after menopause显示文摘SHLIPAK M G SIMON J A VITTINGHOFF E 2000JAMA2000,283,14:1
3Moderate ascites identifies patients with low model for end stage liver disease scores awaiting liver transplantation who have a high mortality risk显示文摘Somsouk M Kornfield R Vittinghoff E 2011Liver Transpl2011,17,2:1
4Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study显示文摘Park M Vittinghoff E Shlipak MG 2014Am Heart J2014,168,6:1
5Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease显示文摘WHOOLEY M A DE JONGE P VITTINGHOFF E 2008JAMA2008,300,:1
6Subgroup interactions in the heart and estrogen/progestin replacement study显示文摘Furberg CD Vittinghoff E Davidson M 2002Circulation2002,105,8:1
7Placebo adherence and mortality in the Heart and Estrogen/Progestin Re- placement Study显示文摘PADULA A M PRESSMAN A R VITTINGHOFF E 2012Am J Med2012,125,8:1
8Urinary In- continence in Elderly Women:Findings from the Health, Aging, and Body Composition Study显示文摘Jackson R A Vittinghoff E Kanaya A M 2004Obstet Gynecol2004,104,2:1
9Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems 显示文摘Tsui J I Pletcher M J Vittinghoff E 2006Hepatology2006,44,:1
10Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause显示文摘Schlipak M Simon JA Vittinghoff E 2000Obstet Gynecol Surv2000,55,:1
11Role of solu- ble endothelial cell-selective adhesion molecule bio- marker in albuminuria and kidney function changes in patients with coronary artery disease: the Heart and Soul Study显示文摘Park M Vittinghoff E Ganz P 2014Arterioscler Thromb Vase Biol2014,34,1:1
12Risk factors and secondary prevention in women with heart disease: the Heart and Estrogent progestin Replacement Study 显示文摘Vittinghoff E Shlipak M G Varosy PD 2003Ann Int Med2003,138,2:1
13Associations of N - terminal pro - B - type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study 显示文摘Park M Vittinghoff E Shlipak MG 2014Am Heart J2014,168,6:1
14Subgroup interactions in the Heart and estrogen/progestin replacement study:lessons learned显示文摘Furberg CD Vittinghoff E Davidson M 2002Circulation2002,105,8:1
15Endoscopic and surgical treatments for achalasia: a systematic review and recta- analysis 显示文摘Campos G M Vittinghoff E Rabl C 2009Ann Surg2009,,249:1
16Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy:Results from the Heart and Estrogen/Progestin Replacement Study(HERS)trial显示文摘Hlaky M A Boothroyd D Vittinghoff E 2002JAMA2002,287,5:1
17Depressive symptoms,health behaviors,and risk of cardiovascular events in patients with coronary heart disease显示文摘Whooley M A de Jonge P Vittinghoff E 2008JAMA2008,300,20:1
18Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease 显示文摘Whooley M A de Jonge P Vittinghoff E 2008JAMA2008,300,20:1
19Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy:results from the Heart and Estrogen/ Progestin Replacement Study (HERS) trial显示文摘HIATKY M A BOOTHROYD D VITTINGHOFF E 2002JAMA2002,287,5:1
20Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes 显示文摘HARMAN S M VITTINGHOFF E BRINTON E A 2011Am J Med2011,124,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费